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Summary
Background: Tissue characteristics of coronary plaques can be evaluated using integrated
backscatter intravascular ultrasound (IB-IVUS), while fractional ﬂow reserve (FFRmyo) is an
index of functional coronary stenosis. We assessed the relation between functional stenosis and
the characteristics of plaque tissue using FFRmyo and IB-IVUS.
Methods and results: A total of 17 lesions with 75%-stenosis assessed visually by coronary angiog-
raphy from 17 stable angina patients (64.2± 9.1 years old, 11 males) were studied. IB-IVUS was
evaluated in the most stenotic cross-sectional area. Using commercially available software,
coronary plaques were assessed for calciﬁcation (CA), ﬁbrosis (F), and lipid pool (LP). Lesions
were localized in the left anterior descending artery in 11 patients, the left circumﬂex in 3,
and the right coronary artery in 3. On quantitative coronary angiography, the percent diameter
stenosis (%DS) was 60.5± 7.3%. Plaque burden was 71.4± 9.1%, FFRmyo was 0.74± 0.13. The
tissue component of the plaques was: CA(%), 3.0± 2.4%; F(%), 60.5± 9.6%; LP(%), 37.2± 11.0%.
Signiﬁcant correlation was not observed between %DS or plaque burden and FFRmyo, structural
stenosis and plaque characterization, nor between CA(%) and FFRmyo. There was a positive
correlation between F(%) and FFRmyo (r = 0.62, p < 0.01) and a negative correlation between
LP(%) and FFRmyo (r =−0.52, p < 0.05).
Conclusion: Our ﬁndings indicate that the tissue characteristics of coronary plaques in inter-
mediate lesion affect functional stenosis.
© 2009 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights reserved.
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Introduction
The stability of atherosclerotic plaques is related to their
tissue characteristics. Consequently, clariﬁcation of the pro-
cess underlying acute coronary syndrome and its prevention
requires a fuller understanding of the tissue characterization
of coronary plaques [1,2]. Integrated backscatter intravas-
cular ultrasound (IB-IVUS) is a useful method for analyzing
coronary plaque tissue, and it was previously suggested that
classifying plaques as vulnerable or stable using IB-IVUS is an
effective means of predicting acute coronary syndrome [3].
In addition, the coronary pressure-derived fractional ﬂow
reserve (FFRmyo), which is calculated from the coronary
pressure by pressure wire, is a reliable index of the func-
tional severity of coronary stenosis. An FFRmyo value of 0.75
distinguishes stenoses associated with inducible ischemia
from those that are not [4,5]. Indeed, in patients with sta-
ble chest pain, the most important prognostic factor for the
occurrence of myocardial ischemia is an FFRmyo of <0.75.
Even when treated with percutaneous coronary interven-
tion (PCI), clinical outcomes in patients with FFRmyo values
of <0.75 are signiﬁcantly worse than in patients with func-
tionally insigniﬁcant stenoses (FFRmyo≥ 0.75) [6,7]. Thus,
both functional stenosis and tissue characteristics may be
directly linked to clinical outcome. On the other hand, the
pressure drop increased with increasing fraction of ﬂex-
ible wall for a given ﬂow rate in an in vitro study [8].
We therefore hypothesized that there is an association
between the tissue characteristics of coronary plaque and
functional stenosis in patients with stable coronary heart
disease. We assessed that idea using pressure wires and
IB-IVUS.
Methods
Study design and eligibility
The present study was conducted according to the principles
of the declaration of Helsinki and was approved by the Ethics
Committee of Gifu Prefectural General Medical Center. All
study participants gave written informed consent prior to
enrollment in the study.
Between November 2006 and March 2009, 17 patients
were enrolled in this study. All showed 75% angiographic
stenosis estimated visually on coronary angiography (clas-
siﬁed according to the American Heart Association) in
one artery, which was amenable to PCI. In addition, the
participants had classes I to III angina pectoris (classi-
ﬁed according to the Canadian Cardiovascular Society).
Exclusion criteria were acute coronary syndrome or recent
myocardial infarction (<2 months); a history of myocar-
dial infarction; left main coronary artery stenosis >25%
or high-grade proximal left anterior descending artery
stenosis with signiﬁcant stenosis (≥75%) in other ves-
sels, lesions containing thrombi or with more than mild
calciﬁcation; ostial lesions; when left ventricular angiog-
raphy revealed abnormal wall motions such as asynergy
or diffuse hypokinesis, reduced left ventricular function
(ejection fraction <55%); and signiﬁcant valvular heart
disease.
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ngiographic assessments
ngiography was carried out in two orthogonal views after
ntracoronary administration of 5.0mg of isosorbide dini-
rate. Digital angiograms were analyzed online using an
utomated edge detection system (Good net; Goodman Co.,
td., Nagoya, Japan). Using the guiding catheter as a scal-
ng device, reference diameter, minimum lumen diameter,
nd percent diameter stenosis (%DS) were calculated. The
lgorithm for the cardiovascular measurement system inter-
olated reference-vessel diameters from the diameters of
pparently normal segments just proximal and distal to the
arget lesion.
VUS procedure and IB-IVUS parameters
n the conventional IVUS analysis, cross-sectional images
ere quantiﬁed for lumen cross-sectional area (LCSA),
xternal elastic membrane (EEM) cross-sectional area (CSA),
nd plaque (P) +media (M) cross-sectional area (P +M
SA = EEM CSA− LCSA) using the software included with
he IB-IVUS system. Plaque burden was calculated as P +M
SA/EEM CSA.
Integrated backscatter was evaluated using the section
ontaining the most stenotic site in the IVUS study. A per-
onal computer equipped with custom software (IB-IVUS, YD
o., Ltd., Nara, Japan) was connected to the IVUS imaging
ystem (Galaxy, Boston Scientiﬁc, Natick, MA, USA) to obtain
he radio frequency signal output, signal trigger output, and
ideo image output. Ultrasound backscattered signals were
cquired using a 40MHz rotating IVUS catheter, digitized and
ubjected to spectral analysis. Using a fast Fourier trans-
orm, IB values for each tissue component were calculated
s an average power, measured in decibels, of the frequency
omponent of the backscattered signal from a small volume
f tissue. The representative color-coded maps of the cross-
ectional coronary artery plaques were constructed using
B cut-off points for discriminating calciﬁcation, ﬁbrosis,
nd lipid pools, as described previously [1,2]. The percent
brotic area (ﬁbrotic area/P +M CSA; %FA) and the percent
ipid area (lipid area/P +M CSA; %LA) were automatically cal-
ulated by the IB-IVUS system. The percent high-signal area
the part of the calciﬁcation on the inner surface that could
e measured with the formula of IB-IVUS/P +M CSA) was also
utomatically calculated by IB-IVUS as the high-signal area
%CA).
oronary pressure measurement and calculation of
FRmyo
oronary pressure was measured using a 0.014-inch sensor-
ipped PCI guide wire (PressureWire, Radi Medical Systems,
ppsala, Sweden). The wire was introduced through a
- or 7-F guiding catheter, calibrated, advanced into the
oronary artery, and positioned distal to the stenosis as
escribed previously [4,9]. Adenosine (140g/kg/min) was
dministered intravenously to induce maximum hyperemia
4,10]. FFRmyo was then calculated as the ratio of the
ean hyperemic distal coronary pressure measured with
pressure wire to the mean aortic pressure measured
ith the guiding catheter. The measurement was performed
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wice, and FFRmyo was taken as the average of the two
easurements.
nti-anginal thrombotic treatment
ll patients also received oral therapy consisting of 75mg
f clopidogrel or 200mg of ticlopidine plus 100mg of aspirin
aily. Patients in whom tienopilidines were contraindicated
eceived 100mg of aspirin twice. Anti-ischemia therapy
ncluded a long-acting -blocker, a Ca-blocker, nitrates,
nd nicorandil, alone or in combination, together with
tatins and either an angiotensin II receptor blocker or an
ngiotensin-converting enzyme inhibitor for standard sec-
ndary prevention [11].
tatistical analysis
ontinuous data are expressed as means± SD or as propor-
ions, while categorical data are expressed as frequencies
r percentages. Pearson’s correlation and simple regression
ere used to assess the relation between subjects. Values of
< 0.05 were considered signiﬁcant. All analyses were per-
ormed using SAS software version 5.0 (SAS Institute Inc.,
ary, NC, USA).
esultsharacteristics of the patients and their lesions
he clinical characteristics of the 17 study participants
re shown in Table 1. Among these patients, the mean
F
s
n
c
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Table 1 Patient characteristics and backgrounds.
Patient
no.
Age
(years)
Gender Risk factor
HT HL DM Aspirin Tieno
pilidine
ARB
AC
1 51 M N N Y Y Y Y
2 52 M N N Y Y Y Y
3 67 F Y Y N Y N N
4 66 F Y Y N Y N N
5 61 F Y Y Y Y Y Y
6 62 F Y Y Y Y Y Y
7 63 M N Y Y Y Y N
8 81 M Y Y Y Y Y Y
9 80 M Y Y Y Y Y Y
10 62 M Y N Y Y Y N
11 61 F Y N Y Y Y Y
12 68 M N Y Y Y Y Y
13 67 M N Y Y Y Y Y
14 49 M Y Y N Y Y Y
15 58 M Y Y N Y Y Y
16 74 M Y N N Y Y N
17 70 F Y Y Y Y Y Y
Mean 64.2
SD 9.1
HT, hypertension; HL, hyperlipidemia; DM, diabetes mellitus; ARB, ang
inhibitor; LAD, left anterior descending coronary artery; LCX, left circuS. Tanaka et al.
ge was 64 years (range 49—81), 70.5% had hypertension,
0.5% had hyperlipidemia, and 70.5% had diabetes. Although
high proportion of diabetics was included, this popu-
ation had had improved glucose control by taking only
-glucosidase inhibitor or diet therapy alone. Two patients
moked. Stenotic lesions were localized in the left ante-
ior descending artery in 11 patients, in the left circumﬂex
rtery in 3 patients, and in the right coronary artery in 3
atients. Angiographic backgrounds and IVUS ﬁndings are
ummarized in Table 2. The mean reference-vessel diam-
ter was 2.91mm, and the lesion length was 10.77mm.
uantitative coronary angiography showed the mean min-
mal lumen diameter to be 1.15± 0.46mm and the %DS
o be 60.46± 7.25%. The mean FFRmyo was 0.74 (range
.52—0.98). With conventional IVUS analysis, the mean EEM
as 10.38mm2, and the mean LCSA was 2.88mm2. The
laque burden was 71.36± 9.07%. The %CA at the observa-
ion site evaluated by IB-IVUS was 2.97± 2.35%. The mean
F was 60.48% (range 40.54—74.65%), and the %LP was 37.2%
range 18.01—57.19%).
elation among tissue characteristics, structural
tenosis, and functional stenosis
e found no correlation between FFRmyo and %DS
r =−0.354, p = 0.166, Fig. 1A). Nor was there a correlation
etween FFRmyo and plaque burden (r =−0.241, p = 0.359,
ig. 1B), nor between FFRmyo and minimum lumen cross-
ectional area (r =−0.002, p = 0.995, Fig. 1C). Likewise,
either %DS nor plaque burden correlated with the tissue
haracterization values (Figs. 2 and 3). Fig. 4 shows the rela-
ionship between FFRmyo and tissue characterization. There
Medication Affected
artery
/
E
Statin -
Blocker
Ca-
blocker
Nitrates Nico-
randil
Y N N Y N LAD
Y N N Y N RCA
N N N Y N LAD
N N N Y N LCX
Y N N N N LAD
Y N N N N LCX
N N N Y N RCA
Y N Y Y N LAD
Y N Y Y N LCX
N N N Y Y LAD
N Y N Y N LAD
Y Y N N Y LAD
Y Y N N Y LAD
Y N Y Y N LAD
Y N Y Y N RCA
Y N N N Y LAD
Y N Y N N LAD
iotensin II receptor blocker; ACE, angiotensin-converting enzyme
mﬂex coronary artery; RCA, right coronary artery.
IB and FFR of intermediate coronary stenosis 299
Table 2 Angiographic backgrounds and IVUS ﬁndings.
Patient
no.
Quantitative coronary angiography FFR
myo
IVUS analysis IB-IVUS
RD
(mm)
MLD
(mm)
Stenosis
(%)
Lesion
length
(mm)
EEM
(mm2)
LCSA
(mm2)
P +M
CSA
(mm2)
Plaque
burden
(%)
Calciﬁcation
(%)
Fibrous
(%)
Lipid
(%)
1 3.93 1.97 49.87 10.87 0.82 10.89 4.56 6.33 58.13 0.47 58.42 41.10
2 3.93 1.97 49.87 7.87 0.98 11.33 4.21 7.12 62.84 0.68 70.13 29.19
3 3.36 0.91 72.92 15.23 0.68 8.59 1.44 7.15 83.24 3.25 54.88 41.88
4 2.60 1.40 46.15 11.69 0.57 10.31 2.98 7.33 71.10 2.93 59.34 37.75
5 2.95 0.93 68.47 10.42 0.57 11.99 3.31 8.68 72.39 1.10 55.95 42.95
6 2.58 0.64 75.19 11.80 0.52 12.44 3.57 8.87 71.30 1.15 53.15 45.89
7 2.71 0.74 72.69 6.60 0.95 6.86 1.52 5.34 77.84 2.81 79.18 18.01
8 3.16 1.62 48.73 7.96 0.75 6.57 2.67 3.90 59.36 1.10 65.03 33.87
9 2.62 1.12 57.25 7.26 0.88 7.01 2.39 4.62 65.91 2.39 72.26 25.36
10 2.30 1.07 53.48 5.68 0.78 9.32 3.72 5.60 60.09 6.66 74.65 18.69
11 2.51 0.48 80.88 12.70 0.68 14.05 2.56 11.49 81.78 6.53 57.23 36.24
12 2.51 0.43 82.87 10.08 0.59 9.82 2.99 6.82 69.45 6.04 59.54 34.44
13 3.32 1.41 57.53 6.27 0.84 9.41 3.30 6.12 65.04 7.48 62.32 28.20
14 2.51 1.00 60.16 14.53 0.75 17.37 2.49 14.87 85.61 1.20 50.07 51.71
15 3.22 1.39 56.83 13.08 0.76 9.81 1.47 8.34 85.02 0.62 60.24 49.15
16 2.52 1.01 59.92 15.45 0.69 10.52 2.47 8.05 76.52 3.84 55.20 40.86
17 2.76 1.48 46.38 15.55 0.71 10.10 3.27 6.83 67.60 2.27 40.54 57.19
Mean 2.91 1.15 60.46 10.77 0.74 10.38 2.88 7.50 71.36 2.97 60.48 37.20
SD 0.50 0.46 7.25 3.38 0.13 2.68 0.90 2.60 9.07 2.35 9.56 10.98
RD, reference diameter; MLD, minimum luminal diameter; FFRmyo, myocardial fractional ﬂow reserve; EEM, external elastic membrane;
LCSA, lumen cross-sectional area; P +M CSA, cross-sectional area; IB-IVUS, integrated backscatter intravascular ultrasound.
Figure 1 Relation between structural and functional stenosis. There was no correlation between fractional ﬂow reserve (FFRmyo)
and %diameter stenosis (A), or between FFRmyo and plaque burden (B). Nor was there a correlation between FFRmyo and minimum
lumen cross-sectional area (C).
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Figure 2 Relation between %diameter stenosis and tissue
characterization. There was no correlation between %diam-
eter stenosis and %CA (r = 0.343, p = 0.182), %F (r =−0.024,
p = 0.928), or %LP (r =−0.069, p = 0.796). () %CA = percent cal-
ciﬁcation area; () %F = percent ﬁbrotic area; () %LP = percent
lipid pool area.
Figure 3 Relation between plaque burden and tissue char-
acterization. There was no correlation between plaque burden
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Figure 4 Relation between fractional ﬂow reserve (FFRmyo)
and tissue characterization. There was no correlation between
FFRmyo and %CA (r =−0.068, p = 0.799). In contrast, there
was a signiﬁcant positive correlation between FFRmyo and
%F (r = 0.620, p = 0.0067) and a signiﬁcant negative correla-
tion between FFRmyo and %LP (r =−0.524, p = 0.0293). ()
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ond %CA (r =−0.031, p = 0.909), %F (r =−0.310, p = 0.230), or
LP (r = 0.397, p = 0.116). () %CA = percent calciﬁcation area;
) %F = percent ﬁbrotic area; () %LP = percent lipid pool area.
as no correlation between FFRmyo and %CA (r =−0.068,
= 0.799). By contrast, we observed a signiﬁcant positive
orrelation between FFRmyo and %F (r = 0.620, p = 0.0067),
nd signiﬁcant negative correlation between FFRmyo and
LP (r =−0.524, p = 0.0293).
iscussion
he results of this study indicate: (1) signiﬁcant correlation
as not observed between structural stenoses and FFRmyo;
2) there is no entire correlation between %DS and tissue
haracteristics; (3) ﬁbrous tissue and FFRmyo have posi-
ive correlations; (4) lipid pool and FFRmyo have negative
orrelations.Analysis using IB values enables plaque components to
e classiﬁed with a high degree of accuracy [1,12]. A large
raction of vulnerable plaques are similar to American Heart
ssociation type IV atherosclerotic lesions—–i.e. they contain
dense accumulation lipid that comprises a substantial por-
l
f
t
i
hCA=percent calciﬁcation area; (), %F = percent ﬁbrotic area;
) %LP = percent lipid pool area.
ion of the lesion, but there is no corresponding increase
n the amount of ﬁbrotic tissue [13,14]. When evaluated
sing IB-IVUS, plaques are deemed vulnerable when the lipid
rea is >65% and the ﬁbrotic area is <25% [3]. Although from
hese criteria, our study population were classiﬁed as having
table plaques, those parameters were previously found to
ave low predictive value [3], suggesting that both the tissue
haracterization of the coronary plaque and the mechanical
tress on the plaque need to be taken into account.
The diagnostic accuracy of FFRmyo for assessing func-
ional stenosis is >90%, which is higher than for any other
nvasive or noninvasive test [4,5]. On the other hand, when
FRmyo was used to classify stenoses as likely to be phys-
ologically signiﬁcant (FFRmyo <0.75) or as unlikely to be
igniﬁcant, the overlap of angiographic severity between the
wo groups was so large that it was suggested angiography
ould not be used to predict the absence or presence of
nducible ischemia in individual patients [6,7], which is in
eeping with the present ﬁndings.
Previous studies showed signiﬁcant correlation between
FR and minimum lumen cross-sectional area measured by
VUS [15]. In the present study, this correlation was not
resented. However, as the correlations between FFR and
issue components in the present study were observed,
lthough in highly limited lesions, tissue components might
lay an important role with the functional stenosis. We
ound that the tissue characterization in intermediate lesion
ith stable plaque correlated with FFRmyo, a functional
ndex; the size of the lipid pool was inversely correlated
ith FFRmyo, while ﬁbrotic area was directly correlated
ith FFRmyo. A contradictory impact may have this result
f study; the progression of human atherosclerotic lesions
eads to increasing ﬁbrosis and stenosis. As lesions progress
rom American Heart Association classiﬁcation type I to
ype IV, the changes in their morphology primarily reﬂect
ncreasing accumulation of lipid. With progression to type V,
owever, ﬁbrotic tissue comprised of collagen and smooth
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muscle cells accounts for more of the thickness of the
lesions than does the lipid [13]. Distal pressure, addition-
ally, decreases with the severity of coronary narrowing in
the epicardial artery, contributing to the progression of
atherosclerosis [16]. However, intermediate or moderate
lesions remain separate in terms of functional severity and
angiographic severity [6,7,17]. The increase in ﬁbrotic tissue
is likely an adaptive response to this distal pressure aimed
at redistributing and modulating the mechanical stress [13].
The increased ﬁbrosis may also be an adaptive response to
reduce the elasticity of the artery wall in the area of the
lesion. An earlier in vivo study showed that elasticity in the
area of the stenosis can exacerbate the pressure drop across
the lesion, thereby reducing ﬂow [8].
Earlier studies have also shown that microvascular resis-
tance plays an important role in the pathogenesis of
intermediate lesions and emphasized the importance of
combined pressure and ﬂow velocity measurements when
evaluating coronary lesions and microvascular involvement
[17]. In addition, rupture-prone plaques are not the only
plaques that are vulnerable. All types of atherosclerotic
plaques with a high likelihood of thrombotic complication
and/or rapid progression should be considered vulnerable
[14]. Our ﬁndings suggest that assessment of FFRmyo and IB-
IVUS can provide information about both functional stenosis
of the epicardial coronary artery and the histological char-
acterization of that stenosis. This in turn can be indicative
of the likelihood of a clinical event, even with intermediate
lesions, and provide useful information for making decisions
about therapy.
Study limitations
This study has several important limitations. We evaluated
only a small group of Japanese patients with stable angina
warranting referral for coronary angiography, which limits
the generalizability of the results. We measured FFRmyo at
only one point in time, so unknown or unmeasurable factors
could potentially alter the responses at other points in time.
In our IVUS study, we analyzed only the most stenotic site,
not the whole coronary artery. We did not perform three-
dimensional IB-IVUS, so we could not measure plaque volume
or tissue characterizations volume. However, FFRmyo is an
accurate and speciﬁc index of the severity in whole epi-
cardial coronary artery [4,5], which cannot be assessed by
IVUS. Additionally, the previous study showed that assess-
ment at only the most stenotic site by IB-IVUS was utilized in
detailed prognosis of vulnerable plaque before acute coro-
nary syndrome [3]. We did not evaluate stiffness of coronary
artery. Arterial stiffness was not only one index of pres-
sure drop [8] but also the risk of coronary artery disease
[18]. Although limited by intermediate stenosis in our study,
there can be a difference of coronary artery stiffness. We did
not perform coronary ﬂow reserve measurements, which is
an important value for physiological assessment. This study
included a very high proportion of diabetics (70.5%). How-
ever the population in this study had had improved glucose
control by taking only -glucosidase inhibitor or diet ther-
apy alone. Additionally, a previous study report showed that
diabetic patients had signiﬁcantly larger dense calcium in
plaque than non-diabetic patients. This report showed cal-301
ium was 8.9% in plaque of diabetic patients, and 6.2% in
on-diabetic patients [19]. In our study, the mean calcium
as 3.0%. This could suggest that our study did not reﬂect
ascular functional changes by hyperglycemia. It is a nonran-
omized study in which the study population was small, and
he results reﬂect the experience of only a single center. It
herefore lacks the obvious advantages of a larger, multicen-
er, multinational randomized study. Inclusion criteria for
his study were restrictive, which limited the number of the
tudy participants. That said, intermediate coronary steno-
is and the resultant myocardial ischemia is an important
ssue that affects the daily lives of numerous individuals. We
uggest that a larger, multicenter, multinational randomized
tudy is warranted. Finally, the number of univariate tests
erformed in the present study leads to an increase in type
errors that are inherent in the exploratory approach to
esting for multiple variables.
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